ResMed
871 hedge funds and large institutions have $20.8B invested in ResMed in 2025 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 343 increasing their positions, 285 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
871
Holders Change
+11
Holders Change %
+1.28%
% of All Funds
11.83%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
108
Increased
343
Reduced
285
Closed
84
Calls
$118M
Puts
$340M
Net Calls
-$222M
Net Calls Change
+$108M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$123M |
| 2 |
Barclays
London,
United Kingdom
|
+$88.7M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$78.4M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$72.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.7M |
Top Sellers
| 1 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
-$73.7M |
| 2 |
Bank of New York Mellon
New York
|
-$51M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$49.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$48.8M |
| 5 |
Renaissance Technologies
New York
|
-$43.4M |
